172 related articles for article (PubMed ID: 37300580)
41. Glucocorticoids and 11beta-hydroxysteroid dehydrogenase type 1 in obesity and the metabolic syndrome.
Stimson RH; Walker BR
Minerva Endocrinol; 2007 Sep; 32(3):141-59. PubMed ID: 17912154
[TBL] [Abstract][Full Text] [Related]
42. 11beta-Hydroxysteroid Dehydrogenase Type 1 Regulation by Intracellular Glucose 6-Phosphate Provides Evidence for a Novel Link between Glucose Metabolism and Hypothalamo-Pituitary-Adrenal Axis Function.
Walker EA; Ahmed A; Lavery GG; Tomlinson JW; Kim SY; Cooper MS; Ride JP; Hughes BA; Shackleton CHL; McKiernan P; Elias E; Chou JY; Stewart PM
J Biol Chem; 2007 Sep; 282(37):27030-27036. PubMed ID: 17588937
[TBL] [Abstract][Full Text] [Related]
43. 11beta-hydroxysteroid dehydrogenase type 1 inhibitors as promising therapeutic drugs for diabetes: status and development.
Ge R; Huang Y; Liang G; Li X
Curr Med Chem; 2010; 17(5):412-22. PubMed ID: 20015040
[TBL] [Abstract][Full Text] [Related]
44. Comprehensive chemical analysis of Zhenshu Tiaozhi formula and its effect on ameliorating glucolipid metabolic disorders in diabetic rats.
Cai J; Zhang J; Li S; Lin Y; Xiao X; Guo J
Biomed Pharmacother; 2021 Jan; 133():111060. PubMed ID: 33378969
[TBL] [Abstract][Full Text] [Related]
45. Anti-diabetic and anti-adipogenic effects of a novel selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor in the diet-induced obese mice.
Park JS; Rhee SD; Jung WH; Kang NS; Kim HY; Kang SK; Ahn JH; Kim KY
Eur J Pharmacol; 2012 Sep; 691(1-3):19-27. PubMed ID: 22760069
[TBL] [Abstract][Full Text] [Related]
46. Regulation of 11β-HSD1 by GH/IGF-1 in key metabolic tissues may contribute to metabolic disease in GH deficient patients.
Morgan SA; Berryman DE; List EO; Lavery GG; Stewart PM; Kopchick JJ
Growth Horm IGF Res; 2022 Feb; 62():101440. PubMed ID: 34814007
[TBL] [Abstract][Full Text] [Related]
47. Is the metabolic syndrome an intracellular Cushing state? Effects of multiple humoral factors on the transcriptional activity of the hepatic glucocorticoid-activating enzyme (11beta-hydroxysteroid dehydrogenase type 1) gene.
Iwasaki Y; Takayasu S; Nishiyama M; Tsugita M; Taguchi T; Asai M; Yoshida M; Kambayashi M; Hashimoto K
Mol Cell Endocrinol; 2008 Mar; 285(1-2):10-8. PubMed ID: 18313835
[TBL] [Abstract][Full Text] [Related]
48. Hypothalamic-pituitary-adrenal axis abnormalities in response to deletion of 11beta-HSD1 is strain-dependent.
Carter RN; Paterson JM; Tworowska U; Stenvers DJ; Mullins JJ; Seckl JR; Holmes MC
J Neuroendocrinol; 2009 Nov; 21(11):879-87. PubMed ID: 19602102
[TBL] [Abstract][Full Text] [Related]
49. Extra-adrenal regeneration of glucocorticoids by 11beta-hydroxysteroid dehydrogenase type 1: physiological regulator and pharmacological target for energy partitioning.
Walker BR
Proc Nutr Soc; 2007 Feb; 66(1):1-8. PubMed ID: 17343766
[TBL] [Abstract][Full Text] [Related]
50. Optimal elevation of β-cell 11β-hydroxysteroid dehydrogenase type 1 is a compensatory mechanism that prevents high-fat diet-induced β-cell failure.
Turban S; Liu X; Ramage L; Webster SP; Walker BR; Dunbar DR; Mullins JJ; Seckl JR; Morton NM
Diabetes; 2012 Mar; 61(3):642-52. PubMed ID: 22315313
[TBL] [Abstract][Full Text] [Related]
51. Inhibition of 11β-HSD1 by LG13 improves glucose metabolism in type 2 diabetic mice.
Zhao L; Pan Y; Peng K; Wang Z; Li J; Li D; Tong C; Wang Y; Liang G
J Mol Endocrinol; 2015 Oct; 55(2):119-31. PubMed ID: 26220348
[TBL] [Abstract][Full Text] [Related]
52. Effect of 11β-HSD1 dehydrogenase activity on bone histomorphometry of glucocorticoid-induced osteoporotic male Sprague-Dawley rats.
Elvy Suhana MR; Farihah HS; Faizah O; Nazrun AS; Norazlina M; Norliza M; Ima-Nirwana S
Singapore Med J; 2011 Nov; 52(11):786-93. PubMed ID: 22173247
[TBL] [Abstract][Full Text] [Related]
53. HIS-388, a novel orally active and long-acting 11β-hydroxysteroid dehydrogenase type 1 inhibitor, ameliorates insulin sensitivity and glucose intolerance in diet-induced obesity and nongenetic type 2 diabetic murine models.
Okazaki S; Takahashi T; Iwamura T; Nakaki J; Sekiya Y; Yagi M; Kumagai H; Sato M; Sakami S; Nitta A; Kawai K; Kainoh M
J Pharmacol Exp Ther; 2014 Oct; 351(1):181-9. PubMed ID: 25100752
[TBL] [Abstract][Full Text] [Related]
54. 11β-hydroxysteroid dehydrogenase-1 deficiency alters brain energy metabolism in acute systemic inflammation.
Verma M; Kipari TMJ; Zhang Z; Man TY; Forster T; Homer NZM; Seckl JR; Holmes MC; Chapman KE
Brain Behav Immun; 2018 Mar; 69():223-234. PubMed ID: 29162555
[TBL] [Abstract][Full Text] [Related]
55. Upregulation of hepatic 11β-hydroxysteroid dehydrogenase-1 expression in calcium-deficient rats.
Takaya J; Iharada A; Okihana H; Kaneko K
Ann Nutr Metab; 2011; 59(2-4):73-8. PubMed ID: 22142627
[TBL] [Abstract][Full Text] [Related]
56. Benzofuran derivatives inhibit 11β-hydroxysteroid dehydrogenase type 1 activity in rat adipose tissue.
Kiyonaga D; Tagawa N; Yamaguchi Y; Wakabayashi M; Kogure T; Ueda M; Miyata O; Kobayashi Y
Biol Pharm Bull; 2012; 35(8):1275-80. PubMed ID: 22863925
[TBL] [Abstract][Full Text] [Related]
57. 11beta-Hydroxysteroid dehydrogenase 1 reductase activity is dependent on a high ratio of NADPH/NADP(+) and is stimulated by extracellular glucose.
Dzyakanchuk AA; Balázs Z; Nashev LG; Amrein KE; Odermatt A
Mol Cell Endocrinol; 2009 Mar; 301(1-2):137-41. PubMed ID: 18778749
[TBL] [Abstract][Full Text] [Related]
58. Decreased Npas4 and Arc mRNA Levels in the Hippocampus of Aged Memory-Impaired Wild-Type But Not Memory Preserved 11β-HSD1 Deficient Mice.
Qiu J; Dunbar DR; Noble J; Cairns C; Carter R; Kelly V; Chapman KE; Seckl JR; Yau JL
J Neuroendocrinol; 2016 Jan; 28(1):n/a. PubMed ID: 26563879
[TBL] [Abstract][Full Text] [Related]
59. Type 2 diabetes and metabolic syndrome are associated with increased expression of 11beta-hydroxysteroid dehydrogenase 1 in obese subjects.
Alberti L; Girola A; Gilardini L; Conti A; Cattaldo S; Micheletto G; Invitti C
Int J Obes (Lond); 2007 Dec; 31(12):1826-31. PubMed ID: 17593901
[TBL] [Abstract][Full Text] [Related]
60. Repeated maternal dexamethasone treatments in late gestation increases 11beta-hydroxysteroid dehydrogenase type 1 expression in the hippocampus of the newborn rat.
Wan S; Hao R; Sun K
Neurosci Lett; 2005 Jul 1-8; 382(1-2):96-101. PubMed ID: 15911129
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
